Considerations for cancer immunotherapy biomarker research during COVID-19

Endocr Relat Cancer. 2020 Sep;27(9):C1-C8. doi: 10.1530/ERC-20-0187.
No abstract available

MeSH terms

  • Betacoronavirus*
  • Biomarkers
  • Biomedical Research
  • C-Reactive Protein / analysis
  • CD8-Positive T-Lymphocytes / immunology
  • COVID-19
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / immunology*
  • HLA-DR Antigens / analysis
  • Humans
  • Immunotherapy*
  • Interleukin-6 / blood
  • Neoplasms / drug therapy*
  • Neoplasms / immunology
  • Pandemics
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / immunology*
  • SARS-CoV-2

Substances

  • Biomarkers
  • HLA-DR Antigens
  • Interleukin-6
  • C-Reactive Protein